This is a Validated Antibody Database (VAD) review about rat Map2k1, based on 160 published articles (read how Labome selects the articles), using Map2k1 antibody in all methods. It is aimed to help Labome visitors find the most suited Map2k1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Map2k1 synonym: Mek1

Knockout validation
Cell Signaling Technology
mouse monoclonal (61B12)
  • western blot knockout validation; human; fig 1
  • western blot knockout validation; mouse; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 2352) was used in western blot knockout validation on human samples (fig 1) and in western blot knockout validation on mouse samples (fig 6). Oncotarget (2016) ncbi
Abcam
domestic rabbit monoclonal (EPR3338)
  • western blot; mouse; loading ...; fig s4i
Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on mouse samples (fig s4i). Nat Commun (2021) ncbi
domestic rabbit monoclonal (MEK1S298-H8)
  • western blot; human; loading ...; fig 7
Abcam Map2k1 antibody (Abcam, ab278562) was used in western blot on human samples (fig 7). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5f
Abcam Map2k1 antibody (Abcam, ab194754) was used in western blot on human samples at 1:1000 (fig 5f). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR3338)
  • western blot; human; loading ...; fig 4a
Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on human samples (fig 4a). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Abcam Map2k1 antibody (Abcam, ab194754) was used in western blot on human samples (fig 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit monoclonal (E342)
  • western blot; human; loading ...; fig e6l
Abcam Map2k1 antibody (Abcam, ab32091) was used in western blot on human samples (fig e6l). Nature (2019) ncbi
domestic rabbit monoclonal (EPR3338)
  • western blot; human; 1:1000; loading ...; fig 5a
Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on human samples at 1:1000 (fig 5a). Mol Carcinog (2019) ncbi
domestic rabbit monoclonal (EPR3338)
  • western blot; mouse; 1:3000; fig 5a
Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on mouse samples at 1:3000 (fig 5a). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (EPR3338)
  • western blot; human; 1:1000; fig 4
Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on human samples at 1:1000 (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR3338)
  • western blot; human; 1:1000; loading ...; fig 2a
In order to describe the antitumoral mechanism of vitamin C in KRAS mutant colorectal cancer that is related to the Warburg effect, Abcam Map2k1 antibody (Abcam, ab96379) was used in western blot on human samples at 1:1000 (fig 2a). Oncotarget (2016) ncbi
Invitrogen
domestic rabbit recombinant (SR13-07)
  • western blot; mouse; loading ...; fig 5a
Invitrogen Map2k1 antibody (Thermo Fisher, MA5-31998) was used in western blot on mouse samples (fig 5a). Front Immunol (2022) ncbi
mouse monoclonal (3D9)
  • proximity ligation assay; human; 1:100; fig 8
In order to elucidate how protein tyrosine phosphatase interacting protein 51 modulates the NF-kappaB signaling pathway, Invitrogen Map2k1 antibody (Life Technologies, 13-3500) was used in proximity ligation assay on human samples at 1:100 (fig 8). Biomolecules (2015) ncbi
domestic rabbit polyclonal
In order to study the molecular mechanisms underlying malignant changes of meningioma cells, Invitrogen Map2k1 antibody (Invitrogen, 44460G) was used . Oncotarget (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (9G3)
  • western blot; human; loading ...; fig 6b
Santa Cruz Biotechnology Map2k1 antibody (Santa Cruz Biotechnology, sc-81504) was used in western blot on human samples (fig 6b). BMC Cancer (2015) ncbi
mouse monoclonal (H-8)
  • western blot; rat; fig 5
Santa Cruz Biotechnology Map2k1 antibody (Santa Cruz, sc-6250) was used in western blot on rat samples (fig 5). Mar Drugs (2015) ncbi
mouse monoclonal (B-4)
  • western blot; human; fig 6
In order to test if celastrol inhibits formation of neutrophil extracellular traps induced by inflammatory stimuli associated with rheumatoid arthritis and systemic lupus erythematosus, Santa Cruz Biotechnology Map2k1 antibody (Santa Cruz Biotechnology, sc-271914) was used in western blot on human samples (fig 6). Curr Mol Med (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; loading ...; fig 2a, 2c
Cell Signaling Technology Map2k1 antibody (CST, 9154S) was used in western blot on human samples at 1:1000 (fig 2a, 2c). Cell Death Discov (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on human samples (fig 2g). Cancer Discov (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig s3d
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples (fig s3d). J Immunother Cancer (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 4g). J Clin Invest (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 1b, s11a
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9154) was used in western blot on mouse samples (fig 1b, s11a). Oncogene (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples at 1:1000 (fig 4b). Life Sci Alliance (2022) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; rat; 1:1000
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 3958) was used in western blot on rat samples at 1:1000. Sci Adv (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 5c). Ther Adv Urol (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:500-1:1000; loading ...; fig s1a
  • western blot; mouse; 1:500-1:1000; loading ...; fig 1a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples at 1:500-1:1000 (fig s1a) and in western blot on mouse samples at 1:500-1:1000 (fig 1a). Nat Commun (2021) ncbi
mouse monoclonal (61B12)
  • western blot; mouse; 1:500-1:1000; loading ...; fig 1a
  • western blot; human; 1:500-1:1000; loading ...; fig s1a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 2352) was used in western blot on mouse samples at 1:500-1:1000 (fig 1a) and in western blot on human samples at 1:500-1:1000 (fig s1a). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9128S) was used in western blot on human samples at 1:1000 (fig 7e). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9124S) was used in western blot on human samples at 1:1000 (fig 7e). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Map2k1 antibody (Cell Signalin, 9121) was used in western blot on human samples (fig 1c). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 7f
Cell Signaling Technology Map2k1 antibody (CST, 9121s) was used in western blot on rat samples (fig 7f). Circulation (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 7a, 7e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on mouse samples at 1:1000 (fig 7a, 7e). elife (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 2e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples at 1:1000 (fig 2e). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 3g, s3b, s8
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 3g, s3b, s8). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on mouse samples at 1:1000 (fig 6a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 8a
Cell Signaling Technology Map2k1 antibody (CST, 9154s) was used in western blot on mouse samples at 1:1000 (fig 8a). Oxid Med Cell Longev (2021) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples (fig 4c). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 6c). elife (2020) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 5d
Cell Signaling Technology Map2k1 antibody (Cell Signaling technology, 9154) was used in western blot on mouse samples (fig 5d). Cell Res (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9121) was used in western blot on human samples (fig 4g). Cell (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2500; fig 1a
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9121) was used in western blot on human samples at 1:2500 (fig 1a). Oncogene (2020) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 7e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 7e). Mol Cancer (2020) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples . elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig e6d
Cell Signaling Technology Map2k1 antibody (CST, 9121) was used in western blot on human samples at 1:1000 (fig e6d). Nature (2019) ncbi
mouse monoclonal (61B12)
  • western blot; human; loading ...; fig s6b
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 61B12) was used in western blot on human samples (fig s6b). Science (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples (fig 6b). Braz J Med Biol Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig e2b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 3i). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9121) was used in western blot on human samples at 1:1000 (fig 4g). EMBO J (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on human samples (fig 4a). J Immunol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9121) was used in western blot on human samples at 1:1000 (fig 3). Sci Rep (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig e4e
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples (fig e4e). Nature (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 1b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples (fig 1b). Cell Stem Cell (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig e6d
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples (fig e6d). Nature (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:2000; loading ...; fig 1e
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9154) was used in western blot on mouse samples at 1:2000 (fig 1e). Science (2019) ncbi
mouse monoclonal (61B12)
  • western blot; human; 1:2000; loading ...; fig 8a
  • western blot; mouse; 1:2000; loading ...; fig 8b
Cell Signaling Technology Map2k1 antibody (CST, 2352S) was used in western blot on human samples at 1:2000 (fig 8a) and in western blot on mouse samples at 1:2000 (fig 8b). J Cell Sci (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 1a
  • western blot; mouse; loading ...; fig 1h
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples (fig 1a) and in western blot on mouse samples (fig 1h). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d, s1b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 1d, s1b). Cell (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples at 1:1000 (fig 6a). Lab Invest (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:2000; loading ...; fig 3a
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples at 1:2000 (fig 3a). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 6a
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples (fig 6a). Hepatology (2019) ncbi
mouse monoclonal (61B12)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 2352) was used in western blot on human samples (fig 5d). Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9121) was used in western blot on human samples (fig 5d). Cancer Res (2019) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 2a). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s10c
  • western blot; human; loading ...; fig s10b, s10d
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on mouse samples (fig s10c) and in western blot on human samples (fig s10b, s10d). Science (2018) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 7a
Cell Signaling Technology Map2k1 antibody (cell signaling technology, 9154s) was used in western blot on mouse samples at 1:1000 (fig 7a). J Mol Cell Cardiol (2018) ncbi
mouse monoclonal (61B12)
  • flow cytometry; mouse; loading ...; fig s1a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 61B12) was used in flow cytometry on mouse samples (fig s1a). Cell Stem Cell (2018) ncbi
domestic rabbit polyclonal
  • flow cytometry; mouse; 1:100-1:200; loading ...; fig s4c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in flow cytometry on mouse samples at 1:100-1:200 (fig s4c). Cell Stem Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s11a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121S) was used in western blot on mouse samples (fig s11a). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (30C8)
  • western blot; mouse; loading ...; fig s11a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9146S) was used in western blot on mouse samples (fig s11a). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (41G9)
  • other; human; loading ...; fig 4c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples at 1:1000 (fig 1e). Science (2018) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 5a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples (fig 5a). Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s3b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121S) was used in western blot on mouse samples (fig s3b). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on human samples (fig 6). Sci Rep (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig s5o
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig s5o). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9121) was used in western blot on human samples (fig 7a). Cancer Lett (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 6b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on mouse samples at 1:1000 (fig 6b). Nat Commun (2017) ncbi
mouse monoclonal (61B12)
  • western blot; mouse; 1:1000; loading ...; fig 6b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 2352) was used in western blot on mouse samples at 1:1000 (fig 6b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 6f
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 6f). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1c
Cell Signaling Technology Map2k1 antibody (Cell signal, 9121s) was used in western blot on human samples (fig s1c). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 1b). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:50; fig 5b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on mouse samples at 1:50 (fig 5b). J Cell Biol (2017) ncbi
mouse monoclonal (61B12)
  • western blot; human; loading ...; fig 3b
In order to show that PHB1 is highly expressed in non-small cell lung cancers patients and correlates with poor survival, Cell Signaling Technology Map2k1 antibody (Cell Signalling, 2352) was used in western blot on human samples (fig 3b). Oncogene (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 3c
In order to show that PHB1 is highly expressed in non-small cell lung cancers patients and correlates with poor survival, Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9154) was used in western blot on human samples (fig 3c). Oncogene (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 3e
In order to find a role for IL-4 in promoting breast cancer aggressiveness, Cell Signaling Technology Map2k1 antibody (CST, 41G9) was used in western blot on human samples (fig 3e). Cancer Res (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 7b
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 3958) was used in western blot on mouse samples at 1:1000 (fig 7b). Toxicol Appl Pharmacol (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 3a). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 1b
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology Map2k1 antibody (cell signalling, 9154) was used in western blot on human samples (fig 1b). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (41G9)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig EV3e
Cell Signaling Technology Map2k1 antibody (cell signalling, 9154) was used in western blot on human samples (fig EV3e). EMBO J (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Map2k1 antibody (cell signalling, 9154) was used in western blot on human samples at 1:1000 (fig 5c). Sci Rep (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 7a
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on mouse samples (fig 7a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples (fig 5b). Cell (2017) ncbi
mouse monoclonal (61B12)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 2352) was used in western blot on human samples (fig 5b). Cell (2017) ncbi
domestic rabbit monoclonal (41G9)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; loading ...; fig s4d
Cell Signaling Technology Map2k1 antibody (Cell signaling, 41G9) was used in western blot on human samples at 1:1000 (fig s4d). J Cell Sci (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 2a
Cell Signaling Technology Map2k1 antibody (cell signalling, 9154) was used in western blot on mouse samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2c
In order to determine the role of p21-activated kinases in response to BRAF inhibitors, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 2c). Mol Carcinog (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; rat; 1:1000; loading ...; fig 4a
In order to examine changes in hippocampal S1PR1 expression after traumatic brain injury and the effects on neurogenesis and neurocognitive function, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on rat samples at 1:1000 (fig 4a). Neural Plast (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 7a
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on mouse samples (fig 7a). J Am Heart Assoc (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Map2k1 antibody (cell signalling, 9154) was used in western blot on human samples (fig 5a). PLoS Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...
In order to clarify the impact of PI3K and PKA signaling to tongue epithelial differentiation, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in immunohistochemistry - paraffin section on mouse samples . Acta Histochem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology Map2k1 antibody (CST, 9121S) was used in western blot on human samples (fig 6d). Nat Chem Biol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:3000; loading ...; fig 5f
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples at 1:3000 (fig 5f). Cell Cycle (2016) ncbi
mouse monoclonal (61B12)
  • western blot knockout validation; human; fig 1
  • western blot knockout validation; mouse; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 2352) was used in western blot knockout validation on human samples (fig 1) and in western blot knockout validation on mouse samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:5000; loading ...; fig 4d
In order to demonstrate the bipartite role of Hsp90 in chaperoning CRAF kinase, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 41G9) was used in western blot on human samples at 1:5000 (fig 4d). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9121) was used in western blot on human samples at 1:1000 (fig 5a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9124) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (30C8)
In order to identify and characterize a DYRK1A inhibitor, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9146) was used . Dis Model Mech (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology Map2k1 antibody (CST, 9121) was used in western blot on human samples at 1:1000 (fig 6). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3f
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9127) was used in western blot on human samples (fig 3f). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9121) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3f
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9124) was used in western blot on human samples (fig 3f). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5
Cell Signaling Technology Map2k1 antibody (cell signalling, 9121) was used in western blot on human samples at 1:1000 (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 3
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples (fig 3). FASEB J (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 2a
In order to develop a patient-derived xenograft platform and use it to identify genes that contribute the cancer resistance of melanoma patients treated with BRAF inhibitors, Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples (fig 2a). Cell Rep (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 2
In order to analyze prevention of BECN2-mediated drug tolerance to cannabioids by autophagy activation by novel inducers, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 2). Autophagy (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig s4
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154P) was used in western blot on human samples at 1:1000 (fig s4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 4c). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples (fig 1c). Leukemia (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000; loading ...; fig 6a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on mouse samples at 1:1000 (fig 6a). J Am Heart Assoc (2016) ncbi
domestic rabbit monoclonal (30C8)
  • western blot; human; 1:3000; fig 8
In order to study kinase DYRK1A selective inhibition by targeting its folding process, Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9146BC) was used in western blot on human samples at 1:3000 (fig 8). Nat Commun (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig 3
In order to analyze the induction of the phosphorylation of EGFR and downregulation of cdc25C and MEK phosphorylation by CD147-targeted siRNA in A375 malignant melanoma cells, Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples at 1:1000 (fig 3). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:5000; fig 2
Cell Signaling Technology Map2k1 antibody (Cell Signaling Tech, 9154S) was used in western blot on human samples at 1:5000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 5
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, Cell Signaling Technology Map2k1 antibody (Cell signaling, 9121S) was used in western blot on human samples at 1:500 (fig 5). elife (2016) ncbi
domestic rabbit monoclonal (41G9)
  • immunohistochemistry - paraffin section; human; 1:400; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig s1). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples at 1:1000 (fig 1). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; rat; 1:1000; fig 5
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on rat samples at 1:1000 (fig 5). J Am Heart Assoc (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; tbl 2
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples at 1:1000 (tbl 2). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Map2k1 antibody (Cell Signaling Tech, 9127S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 5
  • western blot; human; fig 1
Cell Signaling Technology Map2k1 antibody (Cell Signaling Tech, 9154) was used in western blot on mouse samples (fig 5) and in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to characterize colorectal cancer and nuclear localization of YBX1 and uncoupling of EGFR-RAS signaling, Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9121) was used in western blot on human samples at 1:1000 (fig 4). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 1
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on mouse samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to study Val600 in the activation portion of BRAF and its peculiar yin-yang of kinase activation and unfolding, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9121) was used in western blot on human samples (fig 3). elife (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 2b
In order to study the role of polo-like kinase 1 in essential functions of alloreactive T cells, Cell Signaling Technology Map2k1 antibody (Cell signaling, 41G9) was used in western blot on human samples (fig 2b). Immunol Res (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 5
  • western blot; human; fig 5
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples (fig 5) and in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 4
In order to learn the requirement for embryonic poly(A)-binding protein (EPAB) in female mice to provide granulosa cell EGF signaling and cumulus expansion, Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154p) was used in western blot on mouse samples (fig 4). Endocrinology (2016) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig s6
In order to develop new methods to study phosphoproteins, Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples (fig s6). Nat Commun (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
In order to study the molecular signaling responsible for retinoic acid-induced differentiation, Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; hamsters; loading ...; fig 2f
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on hamsters samples (fig 2f). elife (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples at 1:1000 (fig 1). Cancers (Basel) (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 1
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples . Cell Signal (2015) ncbi
mouse monoclonal (61B12)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (CST, 2352) was used in western blot on human samples . Cell Signal (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; fig 4
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples (fig 4). Mol Biol Cell (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig S3
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples (fig S3). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:400; loading ...; fig 6g
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples at 1:400 (fig 6g). Biochim Biophys Acta (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig s5b
Cell Signaling Technology Map2k1 antibody (CST, 9154) was used in western blot on human samples (fig s5b). Oncotarget (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples . Basic Res Cardiol (2015) ncbi
domestic rabbit monoclonal (41G9)
  • reverse phase protein lysate microarray; human; tbl s2
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154S) was used in reverse phase protein lysate microarray on human samples (tbl s2). Mol Syst Biol (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig s3
Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples (fig s3). Pigment Cell Melanoma Res (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on human samples (fig 2a). Mol Carcinog (2016) ncbi
domestic rabbit monoclonal (30C8)
  • western blot; human; 1:1000; fig  6
Cell Signaling Technology Map2k1 antibody (Cell Signalling Technology, 9146) was used in western blot on human samples at 1:1000 (fig  6). Cell Signal (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000; fig  6
Cell Signaling Technology Map2k1 antibody (Cell Signalling Technology, 9154) was used in western blot on human samples at 1:1000 (fig  6). Cell Signal (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 6
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 6). Cell Res (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; loading ...; fig 2g
In order to investigate the role of GNB1 and GNB2 in cancer cells., Cell Signaling Technology Map2k1 antibody (Cell signaling, 9154) was used in western blot on human samples (fig 2g). Nat Med (2015) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; rat
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on rat samples . Int J Mol Med (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signalling, 9154) was used in western blot on human samples . Cell Microbiol (2014) ncbi
mouse monoclonal (61B12)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 2352) was used in western blot on human samples . Mol Biol Cell (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples . Mol Biol Cell (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; 1:1000
Cell Signaling Technology Map2k1 antibody (Cell Signaling, #9154P) was used in western blot on human samples at 1:1000. J Mol Histol (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples . Pigment Cell Melanoma Res (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse; 1:1000
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples at 1:1000. Biochim Biophys Acta (2014) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human; fig 2a
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154) was used in western blot on human samples (fig 2a). Cancer Res (2013) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; human
Cell Signaling Technology Map2k1 antibody (Cell Signaling, 9154S) was used in western blot on human samples . J Biol Chem (2013) ncbi
domestic rabbit monoclonal (41G9)
  • western blot; mouse
Cell Signaling Technology Map2k1 antibody (Cell Signaling Technology, 9154) was used in western blot on mouse samples . PLoS ONE (2013) ncbi
BD Biosciences
mouse monoclonal (25/MEK1)
  • western blot; human; fig s2
BD Biosciences Map2k1 antibody (BD Transduction Laboratories, 610121) was used in western blot on human samples (fig s2). Cell Commun Signal (2016) ncbi
Articles Reviewed
  1. Mukherjee B, Tiwari A, Palo A, Pattnaik N, Samantara S, Dixit M. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. Cell Death Discov. 2022;8:442 pubmed publisher
  2. Chen S, Vedula R, Cuevas Navarro A, Lu B, Hogg S, Wang E, et al. Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. Cancer Discov. 2022;12:2434-2453 pubmed publisher
  3. Huang J, Wang X, Li B, Shen S, Wang R, Tao H, et al. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. J Immunother Cancer. 2022;10: pubmed publisher
  4. Zou Y, Chen Z, Zhang X, Yu J, Xu H, Cui J, et al. Targeting PCSK9 Ameliorates Graft Vascular Disease in Mice by Inhibiting NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells. Front Immunol. 2022;13:894789 pubmed publisher
  5. Luo Y, Li Z, Kong Y, He W, Zheng H, An M, et al. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Invest. 2022;132: pubmed publisher
  6. Kidger A, Saville M, Rushworth L, Davidson J, Stellzig J, Ono M, et al. Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6. Oncogene. 2022;41:2811-2823 pubmed publisher
  7. Grinat J, Kosel F, Goveas N, Kranz A, Alexopoulou D, Rajewsky K, et al. Epigenetic modifier balances Mapk and Wnt signalling in differentiation of goblet and Paneth cells. Life Sci Alliance. 2022;5: pubmed publisher
  8. Valussi M, Besser J, Wystub Lis K, Zukunft S, Richter M, Kubin T, et al. Repression of Osmr and Fgfr1 by miR-1/133a prevents cardiomyocyte dedifferentiation and cell cycle entry in the adult heart. Sci Adv. 2021;7:eabi6648 pubmed publisher
  9. Kareddula A, Medina D, Petrosky W, Dolfi S, Tereshchenko I, Walton K, et al. The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype. Ther Adv Urol. 2021;13:17562872211022462 pubmed publisher
  10. Tan X, Tong L, Li L, Xu J, Xie S, Ji L, et al. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation. Nat Commun. 2021;12:4853 pubmed publisher
  11. Vichas A, Riley A, Nkinsi N, Kamlapurkar S, Parrish P, Lo A, et al. Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nat Commun. 2021;12:4789 pubmed publisher
  12. Li L, Yang Q, Jiang Y, Yang W, Jiang Y, Li X, et al. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer. Nat Commun. 2021;12:4362 pubmed publisher
  13. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  14. Zhang Y, Ding L, Ni Q, Tao R, Qin J. Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis. Aging (Albany NY). 2021;13:16786-16803 pubmed publisher
  15. Zhang Y, Da Q, Cao S, Yan K, Shi Z, Miao Q, et al. HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression. Circulation. 2021;144:638-654 pubmed publisher
  16. Li D, Chen J, Guo J, Li L, Cai G, Chen S, et al. A phosphorylation of RIPK3 kinase initiates an intracellular apoptotic pathway that promotes prostaglandin2α-induced corpus luteum regression. elife. 2021;10: pubmed publisher
  17. Catalano A, Adlesic M, Kaltenbacher T, Klar R, Albers J, Seidel P, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers (Basel). 2021;13: pubmed publisher
  18. Xue T, Liu X, Zhang M, E Q, Liu S, Zou M, et al. PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer. Adv Sci (Weinh). 2021;8:2002831 pubmed publisher
  19. Ischenko I, D Amico S, Rao M, Li J, Hayman M, Powers S, et al. KRAS drives immune evasion in a genetic model of pancreatic cancer. Nat Commun. 2021;12:1482 pubmed publisher
  20. Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S. Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway. Aging (Albany NY). 2021;13:4962-4975 pubmed publisher
  21. Cao Y, Li L, Liu Y, Chen G, Tao Z, Wang R, et al. I-κB Kinase-ε Deficiency Attenuates the Development of Angiotensin II-Induced Myocardial Hypertrophy in Mice. Oxid Med Cell Longev. 2021;2021:6429197 pubmed publisher
  22. Li S, Zhu Z, Xue M, Pan X, Tong G, Yi X, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021;40:101859 pubmed publisher
  23. Shaaya M, Fauser J, Zhurikhina A, Conage Pough J, Huyot V, Brennan M, et al. Light-regulated allosteric switch enables temporal and subcellular control of enzyme activity. elife. 2020;9: pubmed publisher
  24. Zhou S, Zhang W, Cai G, Ding Y, Wei C, Li S, et al. Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration. Cell Res. 2020;30:1063-1077 pubmed publisher
  25. Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. 2020;181:1596-1611.e27 pubmed publisher
  26. Wu P, Hong S, Starenki D, Oshima K, Shao H, Gestwicki J, et al. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene. 2020;39:4257-4270 pubmed publisher
  27. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  28. Goswami D, Chen D, Yang Y, Gudla P, Columbus J, Worthy K, et al. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior. elife. 2020;9: pubmed publisher
  29. Amendola C, Mahaffey J, Parker S, Ahearn I, Chen W, Zhou M, et al. KRAS4A directly regulates hexokinase 1. Nature. 2019;576:482-486 pubmed publisher
  30. Yoon I, Nam M, Kim H, Moon H, Kim S, Jang J, et al. Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1. Science. 2019;: pubmed publisher
  31. Yang X, Jiang J, Zhang C, Li Y. Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Braz J Med Biol Res. 2019;52:e8934 pubmed publisher
  32. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  33. Kondo Y, Ognjenovic J, Banerjee S, Karandur D, Merk A, Kulhanek K, et al. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases. Science. 2019;366:109-115 pubmed publisher
  34. Gal H, Lysenko M, Stroganov S, Vadai E, Youssef S, Tzadikevitch Geffen K, et al. Molecular pathways of senescence regulate placental structure and function. EMBO J. 2019;38:e100849 pubmed publisher
  35. Wang N, Fan Y, Yuan C, Song J, Yao Y, Liu W, et al. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity. BMC Cancer. 2019;19:764 pubmed publisher
  36. Gu C, Wang L, Zurawski S, Oh S. Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation. J Immunol. 2019;: pubmed publisher
  37. Frischknecht L, Britschgi C, Galliker P, Christinat Y, Vichalkovski A, Gstaiger M, et al. BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly. Sci Rep. 2019;9:7779 pubmed publisher
  38. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed publisher
  39. Wang J, Liu Y, Liu Y, Zheng S, Wang X, Zhao J, et al. Time-resolved protein activation by proximal decaging in living systems. Nature. 2019;569:509-513 pubmed publisher
  40. Cheng Z, Lei Z, Yang P, Si A, Xiang D, Tang X, et al. Exosome-transmitted p120-catenin suppresses hepatocellular carcinoma progression via STAT3 pathways. Mol Carcinog. 2019;: pubmed publisher
  41. Wang E, Dai Z, Ferrante A, Drake C, Christiano A. A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth. Cell Stem Cell. 2019;: pubmed publisher
  42. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  43. Castel P, Cheng A, Cuevas Navarro A, Everman D, Papageorge A, Simanshu D, et al. RIT1 oncoproteins escape LZTR1-mediated proteolysis. Science. 2019;363:1226-1230 pubmed publisher
  44. Zhang S, Liu W, Yang Y, Sun K, Li S, Xu H, et al. Tmem30a Deficiency in endothelial cells impairs cell proliferation and angiogenesis. J Cell Sci. 2019;: pubmed publisher
  45. Stivala S, Codilupi T, Brkic S, Baerenwaldt A, Ghosh N, Hao Shen H, et al. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019;130:1596-1611 pubmed publisher
  46. Yin C, Zhu B, Zhang T, Liu T, Chen S, Liu Y, et al. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis. Cell. 2019;176:1113-1127.e16 pubmed publisher
  47. Dai L, Hu W, Yang Z, Chen D, He B, Chen Y, et al. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Lab Invest. 2019;99:736-748 pubmed publisher
  48. Duan S, Koziol White C, Jester W, Nycholat C, Macauley M, Panettieri R, et al. CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen. J Clin Invest. 2019;129:1387-1401 pubmed publisher
  49. Ye P, Liu J, Xu W, Liu D, Ding X, Le S, et al. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. Hepatology. 2019;69:1946-1964 pubmed publisher
  50. Neel D, Allegakoen D, Olivas V, Mayekar M, Hemmati G, Chatterjee N, et al. Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins. Cancer Res. 2019;79:546-556 pubmed publisher
  51. Bigenzahn J, Collu G, Kartnig F, Pieraks M, Vladimer G, Heinz L, et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science. 2018;362:1171-1177 pubmed publisher
  52. Gerber T, Murawala P, Knapp D, Masselink W, Schuez M, Hermann S, et al. Single-cell analysis uncovers convergence of cell identities during axolotl limb regeneration. Science. 2018;362: pubmed publisher
  53. Cao Y, Xu Y, Auchoybur M, Chen W, He S, Qin W, et al. Regulatory role of IKKɑ in myocardial ischemia/reperfusion injury by the determination of M1 versus M2 polarization of macrophages. J Mol Cell Cardiol. 2018;123:1-12 pubmed publisher
  54. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  55. Ubil E, Caskey L, Holtzhausen A, Hunter D, Story C, Earp H. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128:2356-2369 pubmed publisher
  56. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  57. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920-926 pubmed publisher
  58. Ambrogio C, Köhler J, Zhou Z, Wang H, Paranal R, Li J, et al. KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS. Cell. 2018;172:857-868.e15 pubmed publisher
  59. Kunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, et al. Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell. 2018;33:44-59.e8 pubmed publisher
  60. Macdonald R, Shrimp J, Jiang H, Zhang L, Lin H, Yen A. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. Sci Rep. 2017;7:17406 pubmed publisher
  61. Schafer S, Viswanathan S, Widjaja A, Lim W, Moreno Moral A, Delaughter D, et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017;552:110-115 pubmed publisher
  62. Liang Z, Yang Y, He Y, Yang P, Wang X, He G, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017;411:90-99 pubmed publisher
  63. Tsutsumi R, Harizanova J, Stockert R, Schröder K, Bastiaens P, Neel B. Assay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2. Nat Commun. 2017;8:466 pubmed publisher
  64. Jiang X, Bao Y, Liu H, Kou X, Zhang Z, Sun F, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36:6850-6862 pubmed publisher
  65. Shaffer S, Dunagin M, Torborg S, Torre E, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431-435 pubmed publisher
  66. Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, et al. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017;31:685-696.e6 pubmed publisher
  67. Riemer P, Rydenfelt M, Marks M, van Eunen K, Thedieck K, Herrmann B, et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. J Cell Biol. 2017;216:1567-1577 pubmed publisher
  68. Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36:4778-4789 pubmed publisher
  69. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  70. Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12-25 pubmed publisher
  71. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  72. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  73. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  74. Lafont E, Kantari Mimoun C, Dráber P, De Miguel D, Hartwig T, Reichert M, et al. The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death. EMBO J. 2017;36:1147-1166 pubmed publisher
  75. Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, et al. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771 pubmed publisher
  76. Xiong X, Liu Y, Mei Y, Peng J, Wang Z, Kong B, et al. Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling. Sci Rep. 2017;7:41857 pubmed publisher
  77. Wang T, Yu H, Hughes N, Liu B, Kendirli A, Klein K, et al. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras. Cell. 2017;168:890-903.e15 pubmed publisher
  78. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  79. Jiu Y, Peranen J, Schaible N, Cheng F, Eriksson J, Krishnan R, et al. Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA. J Cell Sci. 2017;130:892-902 pubmed publisher
  80. Decourtye L, Mire E, Clemessy M, Heurtier V, Ledent T, Robinson I, et al. IGF-1 Induces GHRH Neuronal Axon Elongation during Early Postnatal Life in Mice. PLoS ONE. 2017;12:e0170083 pubmed publisher
  81. Kidger A, Rushworth L, Stellzig J, Davidson J, Bryant C, Bayley C, et al. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proc Natl Acad Sci U S A. 2017;114:E317-E326 pubmed publisher
  82. Babagana M, Johnson S, Slabodkin H, Bshara W, Morrison C, Kandel E. P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells. Mol Carcinog. 2017;56:1515-1525 pubmed publisher
  83. Ye Y, Zhao Z, Xu H, Zhang X, Su X, Yang Y, et al. Activation of Sphingosine 1-Phosphate Receptor 1 Enhances Hippocampus Neurogenesis in a Rat Model of Traumatic Brain Injury: An Involvement of MEK/Erk Signaling Pathway. Neural Plast. 2016;2016:8072156 pubmed publisher
  84. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  85. Chao M, Guo J, Cheng W, Zhu X, She Z, Huang Z, et al. Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. J Am Heart Assoc. 2016;5: pubmed publisher
  86. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  87. Li Y, Buijs Gladdines J, Cant Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  88. Jung J, Jung H, Neupane S, Kim K, Kim J, Yamamoto H, et al. Involvement of PI3K and PKA pathways in mouse tongue epithelial differentiation. Acta Histochem. 2017;119:92-98 pubmed publisher
  89. Spencer Smith R, Koide A, Zhou Y, Eguchi R, Sha F, Gajwani P, et al. Inhibition of RAS function through targeting an allosteric regulatory site. Nat Chem Biol. 2017;13:62-68 pubmed publisher
  90. Zimmermann M, Arachchige Don A, Donaldson M, Patriarchi T, Horne M. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival. Cell Cycle. 2016;15:3278-3295 pubmed
  91. Nowacka J, Baumgartner C, Pelorosso C, Roth M, Zuber J, Baccarini M. MEK1 is required for the development of NRAS-driven leukemia. Oncotarget. 2016;7:80113-80130 pubmed publisher
  92. Mitra S, Ghosh B, Gayen N, Roy J, Mandal A. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation. J Biol Chem. 2016;291:24579-24593 pubmed
  93. Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7:71400-71416 pubmed publisher
  94. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  95. Lagares Tena L, García Monclús S, López Alemany R, Almacellas Rabaiget O, Huertas Martínez J, Sáinz Jaspeado M, et al. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway. Oncotarget. 2016;7:56889-56903 pubmed publisher
  96. Kim H, Lee K, Kim A, Choi M, Choi K, Kang M, et al. A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition. Dis Model Mech. 2016;9:839-48 pubmed publisher
  97. Anta B, Pérez Rodríguez A, Castro J, García Domínguez C, Ibiza S, Martínez N, et al. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes. Cell Death Dis. 2016;7:e2311 pubmed publisher
  98. Wang C, Guo S, Wang J, Yan X, Farrelly M, Zhang Y, et al. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget. 2016;7:49597-49610 pubmed publisher
  99. Sun S, Gu X, Gao X, Li Y, Yu H, Xiong W, et al. Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation. Oncotarget. 2016;7:48050-48058 pubmed publisher
  100. Subramaniam S, Ozdener M, Abdoul Azize S, Saito K, Malik B, Maquart G, et al. ERK1/2 activation in human taste bud cells regulates fatty acid signaling and gustatory perception of fat in mice and humans. FASEB J. 2016;30:3489-3500 pubmed
  101. Tuncbag N, Milani P, Pokorny J, Johnson H, Sio T, Dalin S, et al. Network Modeling Identifies Patient-specific Pathways in Glioblastoma. Sci Rep. 2016;6:28668 pubmed publisher
  102. Aguilera O, Muñoz Sagastibelza M, Torrejón B, Borrero Palacios A, del Puerto Nevado L, Martínez Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7:47954-47965 pubmed publisher
  103. Kemper K, Krijgsman O, Kong X, Cornelissen Steijger P, Shahrabi A, Weeber F, et al. BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts. Cell Rep. 2016;16:263-277 pubmed publisher
  104. Kuramoto K, Wang N, Fan Y, Zhang W, Schoenen F, Frankowski K, et al. Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids. Autophagy. 2016;12:1460-71 pubmed publisher
  105. Wang J, Farris A, Xu K, Wang P, Zhang X, Duong D, et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun. 2016;7:11795 pubmed publisher
  106. Zhou B, Ritt D, Morrison D, Der C, Cox A. Protein Kinase CK2? Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2? Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma. J Biol Chem. 2016;291:17804-15 pubmed publisher
  107. Cant Barrett K, Spijkers Hagelstein J, Buijs Gladdines J, Uitdehaag J, Smits W, van der Zwet J, et al. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30:1832-43 pubmed publisher
  108. Xu Z, Mei F, Liu H, Sun C, Zheng Z. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction. J Am Heart Assoc. 2016;5: pubmed publisher
  109. Kii I, Sumida Y, Goto T, Sonamoto R, Okuno Y, Yoshida S, et al. Selective inhibition of the kinase DYRK1A by targeting its folding process. Nat Commun. 2016;7:11391 pubmed publisher
  110. Hatanaka M, Higashi Y, Kawai K, Su J, Zeng W, Chen X, et al. CD147-targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation. Oncol Lett. 2016;11:2424-2428 pubmed
  111. Hernández Bule M, Martinez Botas J, Trillo M, Paíno C, Ubeda A. Antiadipogenic effects of subthermal electric stimulation at 448 kHz on differentiating human mesenchymal stem cells. Mol Med Rep. 2016;13:3895-903 pubmed publisher
  112. An X, Zhao Z, Luo Y, Zhang R, Tang X, Hao D, et al. Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer. Oncotarget. 2016;7:24719-33 pubmed publisher
  113. Chatelle C, Hövermann D, Muller A, Wagner H, Weber W, Radziwill G. Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors. Sci Rep. 2016;6:23713 pubmed publisher
  114. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  115. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  116. Woodfield S, Zhang L, Scorsone K, Liu Y, Zage P. Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression. BMC Cancer. 2016;16:172 pubmed publisher
  117. Yu C, Tang L, Liang C, Chen X, Song S, Ding X, et al. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy. J Am Heart Assoc. 2016;5: pubmed publisher
  118. Bhargava A, Pelech S, Woodard B, Kerwin J, Maherali N. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. elife. 2016;5: pubmed publisher
  119. Zhang Z, Zhang H, Peng T, Li D, Xu J. Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma. Oncol Lett. 2016;11:610-618 pubmed
  120. Hennig A, Markwart R, Wolff K, Schubert K, Cui Y, Prior I, et al. Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal. 2016;14:5 pubmed publisher
  121. Chung S, Moon H, Ju H, Kim D, Cho K, Ribback S, et al. Comparison of liver oncogenic potential among human RAS isoforms. Oncotarget. 2016;7:7354-66 pubmed publisher
  122. Roßner F, Gieseler C, Morkel M, Royer H, Rivera M, Bläker H, et al. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer. Oncogenesis. 2016;5:e187 pubmed publisher
  123. Wandinger S, Lahortiga I, Jacobs K, Klammer M, Jordan N, Elschenbroich S, et al. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. PLoS ONE. 2016;11:e0146100 pubmed publisher
  124. Kiel C, Benisty H, Lloréns Rico V, Serrano L. The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF. elife. 2016;5:e12814 pubmed publisher
  125. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed publisher
  126. Park Y, Kim S, Kwon T, Kim J, Song I, Shin H, et al. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Oncogene. 2016;35:3503-13 pubmed publisher
  127. Yang C, Lowther K, Lalioti M, Seli E. Embryonic Poly(A)-Binding Protein (EPAB) Is Required for Granulosa Cell EGF Signaling and Cumulus Expansion in Female Mice. Endocrinology. 2016;157:405-16 pubmed publisher
  128. Pirman N, Barber K, Aerni H, Ma N, Haimovich A, Rogulina S, et al. A flexible codon in genomically recoded Escherichia coli permits programmable protein phosphorylation. Nat Commun. 2015;6:8130 pubmed publisher
  129. Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang Z, et al. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration. Oncotarget. 2015;6:25856-67 pubmed publisher
  130. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed publisher
  131. Bunaciu R, Jensen H, Macdonald R, Latocha D, Varner J, Yen A. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. PLoS ONE. 2015;10:e0135668 pubmed publisher
  132. Šolman M, Ligabue A, Blaževitš O, Jaiswal A, Zhou Y, Liang H, et al. Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation. elife. 2015;4:e08905 pubmed publisher
  133. Simpson D, Lemonie N, Morgan D, Gaddameedhi S, Kaufmann W. Oncogenic BRAF(V600E) Induces Clastogenesis and UVB Hypersensitivity. Cancers (Basel). 2015;7:1072-90 pubmed publisher
  134. Hutchinson K, Johnson D, Johnson A, Sanchez V, Kuba M, Lu P, et al. ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma. Oncotarget. 2015;6:22348-60 pubmed
  135. Tang X, Chen X, Xu Y, Qiao Y, Zhang X, Wang Y, et al. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells. Cell Signal. 2015;27:1694-702 pubmed publisher
  136. Li P, Sheu M, Ma W, Pan C, Sheu J, Wu C. Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells. Mar Drugs. 2015;13:3046-60 pubmed publisher
  137. Boswell B, Musil L. Synergistic interaction between the fibroblast growth factor and bone morphogenetic protein signaling pathways in lens cells. Mol Biol Cell. 2015;26:2561-72 pubmed publisher
  138. Yu Y, Koehn C, Yue Y, Li S, Thiele G, Hearth Holmes M, et al. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. Curr Mol Med. 2015;15:401-10 pubmed
  139. Tate C, Mc Entire J, Pallini R, Vakana E, Wyss L, Blosser W, et al. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. PLoS ONE. 2015;10:e0125697 pubmed publisher
  140. Brobeil A, Kämmerer F, Tag C, Steger K, Gattenlöhner S, Wimmer M. PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway. Biomolecules. 2015;5:485-504 pubmed publisher
  141. Yang Z, Zheng B, Zhang Y, He M, Zhang X, Ma D, et al. miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells. Biochim Biophys Acta. 2015;1852:1477-89 pubmed publisher
  142. Gupta J, Igea A, Papaioannou M, López Casas P, Llonch E, Hidalgo M, et al. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. Oncotarget. 2015;6:8539-51 pubmed
  143. Bao M, Cai Z, Zhang X, Li L, Liu X, Wan N, et al. Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction. Basic Res Cardiol. 2015;110:25 pubmed publisher
  144. Fallahi Sichani M, Moerke N, Niepel M, Zhang T, Gray N, Sorger P. Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis. Mol Syst Biol. 2015;11:797 pubmed publisher
  145. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed publisher
  146. Silva G, Aboussekhra A. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. Mol Carcinog. 2016;55:525-36 pubmed publisher
  147. Tanaka T, Iino M. Sec8 regulates cytokeratin8 phosphorylation and cell migration by controlling the ERK and p38 MAPK signalling pathways. Cell Signal. 2015;27:1110-9 pubmed publisher
  148. Papadakis A, Sun C, Knijnenburg T, Xue Y, Grernrum W, Hölzel M, et al. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Res. 2015;25:445-58 pubmed publisher
  149. Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94 pubmed
  150. Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, et al. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015;21:71-5 pubmed publisher
  151. Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G, et al. Hepatocyte growth factor regulates the TGF-?1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 2014;34:381-90 pubmed publisher
  152. Eucker T, Samuelson D, Hunzicker Dunn M, Konkel M. The focal complex of epithelial cells provides a signalling platform for interleukin-8 induction in response to bacterial pathogens. Cell Microbiol. 2014;16:1441-55 pubmed publisher
  153. Chapnick D, Liu X. Leader cell positioning drives wound-directed collective migration in TGF?-stimulated epithelial sheets. Mol Biol Cell. 2014;25:1586-93 pubmed publisher
  154. Sun Y, Guo W, Ren T, Liang W, Zhou W, Lu Q, et al. Gli1 inhibition suppressed cell growth and cell cycle progression and induced apoptosis as well as autophagy depending on ERK1/2 activity in human chondrosarcoma cells. Cell Death Dis. 2014;5:e979 pubmed publisher
  155. Wang Z, Ren Z, Hu Z, Hu X, Zhang H, Wu H, et al. Angiotensin-II induces phosphorylation of ERK1/2 and promotes aortic adventitial fibroblasts differentiating into myofibroblasts during aortic dissection formation. J Mol Histol. 2014;45:401-12 pubmed publisher
  156. Choi J, Landrette S, Wang T, Evans P, Bacchiocchi A, Bjornson R, et al. Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors. Pigment Cell Melanoma Res. 2014;27:253-62 pubmed publisher
  157. Zhang Y, Zhang X, Gao L, Liu Y, Jiang D, Chen K, et al. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction. Biochim Biophys Acta. 2014;1842:232-44 pubmed publisher
  158. Paugh B, Zhu X, Qu C, Endersby R, Diaz A, Zhang J, et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res. 2013;73:6219-29 pubmed publisher
  159. Li Y, Takahashi M, Stork P. Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation. J Biol Chem. 2013;288:27646-57 pubmed publisher
  160. Dai J, Shen D, Bian Z, Zhou H, Gan H, Zong J, et al. IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis. PLoS ONE. 2013;8:e53412 pubmed publisher